51.10 USD
-0.16
0.31%
At close Updated Sep 17, 4:00 PM EDT
Pre-market
After hours
51.10
0.00
0%
1 day
-0.31%
5 days
-3.68%
1 month
-4.54%
3 months
4.07%
6 months
-10.79%
Year to date
-26.73%
1 year
-41.39%
5 years
-29.49%
10 years
-2.37%
 

About: Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.

Employees: 2,960

0
Funds holding %
of 7,463 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

32% more repeat investments, than reductions

Existing positions increased: 139 | Existing positions reduced: 105

5.31% more ownership

Funds ownership: 91.04% [Q1] → 96.34% (+5.31%) [Q2]

7% less funds holding

Funds holding: 366 [Q1] → 342 (-24) [Q2]

13% less capital invested

Capital invested by funds: $2.54B [Q1] → $2.22B (-$325M) [Q2]

22% less call options, than puts

Call options by funds: $6.4M | Put options by funds: $8.2M

28% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 72

50% less funds holding in top 10

Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$53
4% upside
Avg. target
$61
19% upside
High target
$65
27% upside

5 analyst ratings

positive
40%
neutral
60%
negative
0%
Morgan Stanley
$60
Equal-Weight
Initiated
8 Sep 2025
BMO Capital
John McNulty
$61
Market Perform
Maintained
2 Sep 2025
Argus Research
Alexandra Yates
$65
Buy
Maintained
26 Aug 2025
UBS
Joshua Spector
$64
Buy
Maintained
7 Aug 2025
Wells Fargo
Michael Sison
$53
Equal-Weight
Maintained
31 Jul 2025

Financial journalist opinion

Negative
Zacks Investment Research
5 days ago
Bear of the Day: Ashland (ASH)
Uncertainty is hitting the chemical makers.
Bear of the Day: Ashland (ASH)
Positive
Zacks Investment Research
20 days ago
Why Is Ashland (ASH) Up 6.7% Since Last Earnings Report?
Ashland (ASH) reported earnings 30 days ago. What's next for the stock?
Why Is Ashland (ASH) Up 6.7% Since Last Earnings Report?
Neutral
Zacks Investment Research
1 month ago
Is the Options Market Predicting a Spike in Ashland Stock?
Investors need to pay close attention to ASH stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Ashland Stock?
Neutral
GlobeNewsWire
1 month ago
Ashland board authorizes quarterly dividend
WILMINGTON, Del., Aug. 08, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock. The dividend will be payable on September 15, 2025, to stockholders of record at the close of business on September 1, 2025.
Ashland board authorizes quarterly dividend
Negative
Zacks Investment Research
1 month ago
Ashland Q3 Earnings and Sales Lag Estimates, Guidance Narrowed
ASH posts a third-quarter loss of $742 million and misses on sales as portfolio cuts weigh. Full-year guidance range is narrowed.
Ashland Q3 Earnings and Sales Lag Estimates, Guidance Narrowed
Neutral
The Motley Fool
1 month ago
Ashland (ASH) Q3 Revenue Falls 15%
Ashland (ASH) Q3 Revenue Falls 15%
Ashland (ASH) Q3 Revenue Falls 15%
Neutral
Seeking Alpha
1 month ago
Ashland Inc. (ASH) Q3 2025 Earnings Call Transcript
Ashland Inc. (NYSE:ASH ) Q3 2025 Earnings Conference Call July 30, 2025 10:00 AM ET Company Participants Alessandra Faccin Assis - Senior VP and GM of Life Sciences & Intermediates Dago Caceres - SVP & General Manager of Specialty Additives Guillermo Novo - Chairman & CEO James P. Minicucci - Senior VP & GM of Personal Care William C.
Ashland Inc. (ASH) Q3 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
1 month ago
Compared to Estimates, Ashland (ASH) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Ashland (ASH) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Compared to Estimates, Ashland (ASH) Q3 Earnings: A Look at Key Metrics
Negative
Zacks Investment Research
1 month ago
Ashland (ASH) Q3 Earnings and Revenues Miss Estimates
Ashland (ASH) came out with quarterly earnings of $1.04 per share, missing the Zacks Consensus Estimate of $1.15 per share. This compares to earnings of $1.49 per share a year ago.
Ashland (ASH) Q3 Earnings and Revenues Miss Estimates
Neutral
GlobeNewsWire
1 month ago
Ashland reports third quarter fiscal 2025 results and narrows full-year outlook range
WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the third quarter of fiscal year 2025, which ended June 30, 2025, and narrows its full-year fiscal 2025 outlook range. Ashland, a global additives and specialty ingredients company, holds leadership positions in high-quality, consumer-focused markets including pharmaceuticals, personal care and architectural coatings.
Ashland reports third quarter fiscal 2025 results and narrows full-year outlook range
Charts implemented using Lightweight Charts™